Significance of cytokeratin markers TPA, TPA(cyk), TPS and CYFRA 21.1 in metastatic disease

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2345-2349

  Van Dalen, A ^a  

^a GROENE HART HOSPITAL   (Netherlands)

Author keywords

CYFRA 21.1; Cytokeratins; TPA; TPA (cyk); TPS

Indexed keywords

CYTOKERATIN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ARTICLE; BREAST DISEASE; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN SECRETION; SERUM;

BREAST DISEASES; FEMALE; HUMANS; KERATINS; NEOPLASM METASTASIS; PEPTIDES; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0029833313     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Björklund B, Björklund V: Antigenicity of pooled human malignant and normal tissue by cyto-immunological technique: Presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy Appl Immunol 10: 153-184, 1957.
2. Björklund B, Björklund V, Wiklund B, Lundstrom R, Ekdahl PH, Hagbard L, Kaijser K, Eklund G, Lüning B: Human tissue polypeptide related to cancer and placenta: I. Preparation and properties; II Assay technique: III Clinical studies of 1483 individuals with cancer and other conditions. In: Immunological techniques for detection of cancer (Bjorklund B. ed). Stockholm, Bonniers, 1973, pp 133-187.
3. Menendez-Botet CJ, Oettgen HF, Pinsky CM, Swarz HK: A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms. Clin Chem 24: 868-872, 1978.
4. Holyoke D, Chu TM: Tissue polypeptide antigen. In: Immunodi agnostics of cancer (Herberman RG and McIntire KR. eds). New York. Mercel Dekker Inc., 1979, pp 513-521.
5. Hagbard L, Sorbe B: Preliminara erfarenheter av TPS (Tissue polypeptide antigen) vid ovarialcancer. Lakartidningen 75: 3433-3435, 1978 with a summary in English.
6. Lüthgens M, Jurgensonn H von: TPA-RIA in clinical cancer diagnosis. In: Protides of the biological fluids (Peeters H, ed). Oxford and New York, Pergamon Press, 1979, pp 263-266.
7. Björklund B, Wiklund B, Luning B, Anderssen K, Kallin E, Björklund V: Radioimmunoassay of TPA. A laboratory test on cancer. TumorDiagnostik 1: 78-84, 1980.
8. Björklund B: On the nature and clinical use of tissue poly peptide antigen (TPA). TumorDiagnostik 1: 9-20, 1980.
9. Lüthgens M, Schlegel G: Verlaufskontrolle mit Tissue Poly peptide Antigen und Carcinoembryonalen Antigen in der Radi oonkologischen Nachsorge und Therapy. TumorDiagnostik 2: 179-188, 1981.
10. Lüthgens M, Schlegel G: Tissue Polypeptide Antigen und Carcinoembryonales Antigen in der Verlaufskontrolle von Tumorpatienten unter zytostatische Chemotherapy. Tumor Diagno-stik und Therapie 3: 120-126, 1982.
11. Oehr P, Fischer L, Kersjes W, Kunath U, Biersack HJ, Sipeer U, Winkler C: Verteilung, Sensitivitat und Spezifitat von TPA, CEA und CEA × TPA Marker-Produktwerten bei Patienten mit gastrointestinalem Karzinom. Tumor Diagnostik und Therapie 3: 195-198, 1982.
12. Dalen A van, Favier J, Eastham WN: Initial experience with TPA as a tumour marker in ovarian malignancy. Tumor Diagnostik and Therapy 5: 20-22, 1984.
13. Bast RC, Klug TL, St.John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths C, Parker T, Zurawski VR, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl J Med 309: 883-887, 1983.
14. Dalen A van, Favier J, Eastham WN: Preliminary observations with a new monoclonal antibody in ovarian carcinoma. Tumor Diagnostik and Therapie 5: 67-69, 1984.
15. Weber K, Osborn M, Moll R, Wiklund B, Lüning B: Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker. EMBO J 3: 2707-2714, 1984.
16. Mellerick DM, Osborn M, Weber K: On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18 and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum. Oncogene 5: 1007-1017, 1990.
17. Björklund B, Björklund V: Biochemische und morphologische Grundlagen von TPA: Fortschritte in Richtung auf eine allgemeinen Marker für aktive Tumoren durch monoklonale Kartierung. In: Tumormarkersystem CEA-TPA. Grundlagen, Methodik, klinische Konkordanz (Lüthgens M, Schlegel G, eds), Leonberg, Tumor Diagnostik 1987, pp 14-29.
18. Björklund B: Tumor markers TPA, TPA-S und cytokeratins. A working hypothesis. Tumordiagn Ther 13: 78-80, 1992.
19. Bodenmüller H, Banauch D, Ofenloch B, Jaworek D, Dessauer A: Technical evaluation of a new automated tumor marker assay: The enzymun-test CYFRA 21.1. In: Tumor Associated Antigens, Oncogenes, Rceptors. Cytokines in Tumor Diagnosis and Therapy at the Beginning of the Nineties (KlapdorR, ed), München, Zuckschwerdt 1992; pp 137-138.
20. Bodenmüller H, Donie F, Kaufmann M, Banauch D: The tumor markers TPA, TPS, TPS (cyk) and CYFRA 21-1 react different with the keratins 8, 18 and 19. Int J Biol Markers 9: 70-74, 1944.
21. Zetterhcrg A, Skern T, Schoherl E, Bergman T, Jörnvall H: Molecular characterization of TPS. Tumor Biol 16: 340, 1995.
22. Sundström BE, Stighrand TI: Cytokeratins and tissue poly peptide antigen. Int J Biol Markers 9: 102-108, 1994.
23. Börmer OP: From tissue polypeptide antigen to specific cytokeratin assays. Tumor Biol 15: 185-187, 1994.
24. Bonfrer JMG, Groeneveld EM, Korse CM, Dalen A van. Oomen LCJM, Ivanyi D: Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumor Biol 15: 210-222. 1994.
25. Bombardieri E, Bogni A, Botti C: The need to define the substances measured in tests for cytokeratins. Int J Biol Markers 9: 254-255, 1994.